Use and abuse of HOMA modeling

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1487-1495

  Wallace, Tara M ^a   Levy, Jonathan C ^a   Matthews, David R ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ABUSE; CELL FUNCTION; COMPUTER MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HOMEOSTASIS; HOMEOSTATIC MODEL ASSESSMENT; INSULIN RESISTANCE; PANCREAS ISLET BETA CELL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; STEADY STATE;

HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIVER; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS;

EID: 2542469144     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1487     Document Type: Review

References (42)

1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
2. Bergman R, Ider Y, Bowden C, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
3. Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J: Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28:1086-1096, 1979
4. Turner RC, Oakley NW, Nabarro JD: Control of basal insulin secretion, with special reference to the diagnosis of insulinomas. Br Med J 2:132-135, 1971
5. Turner RC, Grayburn JA, Newman GB, Nabarro JD: Measurement of the insulin delivery rate in man. J Clin Endocrinol Metab 33:279-286, 1971
6. Bergman RN, Bucolo RJ: Interaction of insulin and glucose in the control of hepatic glucose balance. Am J Physiol 227:1314-1322, 1974
7. Matthews DR, Rudenski AS, Burnett MA, Darling P, Turner RC: The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. Clin Endocrinol Oxf 23:71-79, 1985
8. Reichard GAJ, Jacobs AG, Kimbel P, Hochella NJ, Weinhouse S: Blood glucose replacement rates in normal and diabetic humans. J Appl Physiol 16:789-795, 1961
9. Forbath N, Hetenyi GJ: Glucose dynamics in normal subjects and diabetic patients before and after a glucose load. Diabetes 15:778-789, 1966
10. Insel PA, Liljenquist JE, Tobin JD, Sherwin RS, Watkins P, Andres R, et al.: Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest 55:1057-1066, 1975
11. Rowe GG, Maxwell GM, Castillo CA, Freeman DJ, Crumpton CW: A study in man of cerebral blood flow and cerebral glucose, lactate and pyruvate metabolism before and after eating. J Clin Invest 38:2154-2158, 1959
12. Morgan HE, Henderson MJ, Regan DM, Park CR: Regulation of glucose uptake in muscle. J Biol Chem 236:253-261, 1961
13. Daniel PM, Love ER, Pratt OE: Insulin-stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose. J Physiol 247:273-288, 1975
14. Berger M, Hagg S, Ruderman NB: Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J 146:231-238, 1975
15. Jeanrenaud B, Renold AE: Studies on rat adipose tissue in vitro. J Biol Chem 234:3082-3087, 1959
16. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program (Letter). Diabetes Care 21:2191-2192, 1998
17. Rudenski AS, Matthews DR, Levy JC, Turner RC: Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40:908-917, 1991
18. Wallace TM, Levy JC, Matthews DR: An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomised study. Diabet Med. In press
19. Robbins DC, Andersen L, Bowsher R, Chance R, Dineson B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association's task force on standardization of the insulin assay. Diabetes 45:242-256, 1996
20. Levy J, Morris R, Hammersley M, Turner R: Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance. Am J Physiol (United States) 2:E365-E375, 1999
21. Bonora E, Targher G, Alberichie M, Bonadonna RC, Saggianni F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23:57-63, 2000
22. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818-822, 1999
23. Garcia-Estevez DA, Araujo-Vilar D, Fiestras-Janeiro G, Saavedra-Gonzalez A, Cabezas-Cerrato J: Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. Horm Metab Res 35:13-17, 2003
24. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC: Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 28:401-411, 1985
25. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48:1779-1786, 1999
26. UKPDS Group: U.K. Prospective Diabetes Study 16: Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
27. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H: A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 19:1138-1141, 1996
28. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464-472, 1995
29. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MI: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
30. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y: Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24:362-365, 2001
31. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Hori Y, Yano Y, Adachi Y: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301, 2000
32. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678-687, 1999
33. Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC: Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 34:488-499, 1991
34. Haffner SM, Miettinen H, Stem MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092, 1997
35. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y: Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20:1562-1568, 1997
36. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, Barbato A, D'Elia L, Trevisan M, Farinaro E: Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399-406, 2001
37. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, Knowler WC: Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 22:944-950, 1999
38. Levy JC, Atkinson AB, Bell PM, McCance DR, Hadden DR: Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15:290-296, 1998
39. Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE: The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coron Artery Dis 12:413-423, 2001
40. Costa A, Rios M, Casamitjana R, Gomis R, Conget I: High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients: a study in Catalonia, a Mediterranean community. Diabetes Res Clin Pract 41:191-196, 1998
41. Pickavance L, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JP: Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution. Br J Pharmacol 128:1570-1576, 1999
42. Xia Z, Sniderman AD, Cianflone K: Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277:45874-9, 2002